Create to Innovate for Cancer Care: Guest Speaker Dr. Lisa Quintiliani Boston Medical Center School of Medicine

1. Innovations in Cancer Care: The
CancerControl mHealth System
Lisa Quintiliani, PhD
Assistant Professor of Medicine
Boston University

2. Cancer care continuum
https://www.cancercare.on.ca/pcs/careoverview/cancercontrol/

3. Cancer survivorship
• 5-year year survival rates for women with breast
cancer 90% [ACS]
– Up from 75% in 1975-77
– Disparities: Rate is much lower among African
American women (78%)
• > 2.8 million breast cancer survivors in the U.S.
• Few technology-related solutions among
survivors
• Smartphone ownership now higher among Black
(64%) and Hispanic (60%) vs. White (53%)
populations [Pew Research]

4. Healthy Lifestyle Promotion
• Diet, physical activity, weight management
– Reductions in cancer recurrence
– General chronic disease prevention
CA Cancer J Clin. 2012 Jul-Aug;62(4):275-6. doi: 10.3322/caac.21146. Epub 2012 May 7.
Nutrition and physical activity guidelines for cancer survivors

5. mHealth
• Mobile applications
– Scalability
– Reach
– Automatic/easier to track information
– Can integrate environmental information
– Integrate into health care or community-based
systems

6. System architecture

7. Patient facing client

12. Coach facing client

13. Clinician facing client overview
Dashboard
Overview Drill Down Goals Goals MI

14. Dashboard

15. Patient Overview

16. Data drill down

17. Goal setting & monitoring

18. Chat

19. Counseling

20. Innovation – NCI Provocative
Questions
• Builds on current advances in knowledge
• Builds on issues typically difficult to fix
• Likelihood of short-term progress
• Pathways to long-term goals in cancer control
and prevention
http://provocativequestions.nci.nih.gov

21. Provocative Questions
• Cancer Prevention and Risk
• Mechanisms of Tumor Development or
Recurrence
• Tumor Detection, Diagnosis, and Prognosis
• Cancer Therapy and Outcomes
• Clinical Effectiveness

22. Clinical Effectiveness
What strategies optimize
adoption and
sustainability of guideline
concordant cancer
treatments in community
settings?
What methods and
approaches induce
physicians and health
systems to abandon
ineffective interventions
or discourage adoption of
unproven interventions?
http://provocativequestions.nci.nih.gov/rfa/mainquestions_listview?mqCategory=Group+E

23. Cancer Prevention and Risk
How do decision making
processes influence
habitual behaviors, and
how can that knowledge
be used to design
strategies that lead to
adoption and
maintenance of behaviors
that reduce cancer risk?
How does the level, type,
or duration of physical
activity influence cancer
risk and prognosis?
http://provocativequestions.nci.nih.gov/rfa/mainquestions_listview?mqCategory=Group+A

24. Thank you!
Questions?
Lisa Quintiliani, PhD
Assistant Professor of Medicine
Lmquinti@bu.edu